Latest News
See all →ITM Appoints Annette Breunig as Chief People Officer
- Global HR leader to drive ITM’s long-term human resources strategy, support organizational development and corporate growth
Garching / Munich,…
Read moreITM Presents Dosimetry Data from Phase 3 COMPETE Trial Supporting Favorable Efficacy and Safety Profile with n.c.a. 177Lu-edotreotide (ITM-11) in Patients with Gastroenteropancreatic Neuroendocrine Tumors at EANM 2025 Annual Congress
- Study showed targeted tumor uptake with low healthy organ exposure in broad cohort of 207 patients
- Supports therapeutic potential of ITM’s proprietary…
ITM and TerThera Sign Supply Agreement for Medical Radioisotope Terbium-161
Garching / Munich, Germany, and Breda, the Netherlands, September 24, 2025 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical…
Read more
